Back to the main directory
Press Release
- EUROAPI : Mise à disposition du Document d’Enregistrement Universel 2022, contenant le Rapport Financier Annuel by BusinessWire
- Peyto Exploration & Development Corp. Confirms Monthly Dividend for May 15, 2023 by GlobeNewsWire
- Gatos Silver Provides Bi-Weekly Status Report by GlobeNewsWire
- RYVYL to Announce Fourth Quarter and Full Year 2022 Financial Results on Monday, April 17, 2023 by GlobeNewsWire
- Golden Heaven Group Holdings Ltd. Announces Closing of Initial Public Offering by GlobeNewsWire
- First Bancshares, Inc. Announces First Quarter Results for 2023 by GlobeNewsWire
- Golden Tag Shares to Resume Trading and Provides Update to Its Acquisition of the La Parrilla Silver Mine Complex by GlobeNewsWire
- Scilex Holding Company Announces Final Postponement of Annual Meeting of Stockholders by GlobeNewsWire
- Resolutions Adopted at the General Ordinary Shareholders’ Meeting and Extraordinary Shareholders’ Meeting for Grupo Aeroportuario del Pacifico on April 13, 2023 by GlobeNewsWire
- Hooker Furnishings Reports Fiscal 2023 Results by GlobeNewsWire
- Rovio Entertainment Corp.: Inside information: As part of its strategic review, Rovio Entertainment Corporation confirms that it is in discussions with Sega Sammy Holdings Inc. by GlobeNewsWire
- New Meme Coin DigiToads (TOADS) token to list on BitMart Exchange by EQS Group AG
- Merus annonce la publication d'un résumé sur le pétosemtamab dans l'adénocarcinome gastrique/œsophagien avancé pour une présentation lors de l'Assemblée annuelle 2023 de l'AACR by GlobeNewsWire
- Merus annonce la publication d'un résumé sur le pétosemtamab en monothérapie dans le carcinome à cellules squameuses de la tête et du cou précédemment traité, choisi pour la présentation orale en session plénière lors de l'assemblée annuelle de l'AACR 202 by GlobeNewsWire
- Aðalfundur Síldarvinnslunnar hf. Frambjóðendur til stjórnar og endanlegar tillögur og dagskrá aðalfundar 2023. by GlobeNewsWire
- DiaCarta Announces Five Abstracts Accepted for Presentation at AACR Annual Meeting 2023 by GlobeNewsWire
- Affimed Presents Final Data Demonstrating Safety and Efficacy of AFM13 Phase 2 REDIRECT Study in Patients with Heavily Pretreated Relapsed or Refractory Peripheral T Cell Lymphoma at the American Association for Cancer Research Annual Meeting 2023 by GlobeNewsWire
- EQS-News: MorphoSys and Incyte Announce Five-Year Results of L-MIND Study Showed Prolonged, Durable Responses in Relapsed or Refractory DLBCL Patients Treated with Monjuvi® (tafasitamab-cxix) by EQS Group AG
- AS’i PRFoods 2022/2023. majandusaasta 3. kvartali ja 9 kuu esialgne konsolideeritud auditeerimata müügikäive by GlobeNewsWire
- Meyas Sands Gold Project Update by GlobeNewsWire
- SNBL to Acquire Satsuma Pharmaceuticals by GlobeNewsWire
- Magnite Launches ClearLine, Giving Ad Agencies a New, Efficient Route to Premium Video Inventory by GlobeNewsWire
- Martela Corporation Directs a Share Issue to the Company Itself Without Payment by GlobeNewsWire
- Transgene - Preclinical Results Showing TG6050, a Novel Oncolytic Virus, induces Tumor Regression by Activating Innate and Adaptive immune responses presented at AACR by BusinessWire
- Sampo plc’s share buybacks 14/04/2023 by GlobeNewsWire